BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28283728)

  • 1. Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report.
    Blumfield E; Moore MM; Drake MK; Goodman TR; Lewis KN; Meyer LT; Ngo TD; Sammet C; Stanescu AL; Swenson DW; Slovis TL; Iyer RS
    Pediatr Radiol; 2017 May; 47(6):665-673. PubMed ID: 28283728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of gadolinium-based contrast agents in Ghana with a focus on residual intracranial gadolinium deposition.
    Piersson AD; Gorleku PN
    Radiography (Lond); 2018 Aug; 24(3):e51-e55. PubMed ID: 29976344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.
    Mithal LB; Patel PS; Mithal D; Palac HL; Rozenfeld MN
    Pediatr Radiol; 2017 May; 47(6):657-664. PubMed ID: 28283727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Gadolinium Deposition on Radiology Practice: An International Survey of Radiologists.
    Fitzgerald RT; Agarwal V; Hoang JK; Gaillard F; Dixon A; Kanal E
    Curr Probl Diagn Radiol; 2019; 48(3):220-223. PubMed ID: 29530452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
    Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
    Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric contrast-enhanced ultrasound in the United States: a survey by the Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology.
    Back SJ; Maya C; Darge K; Acharya PT; Barnewolt CE; Coleman JL; Dillman JR; Fordham LA; Hwang M; Lim A; McCarville MB; Munden MM; Paltiel HJ; Volberg FM
    Pediatr Radiol; 2018 Jun; 48(6):852-857. PubMed ID: 29442152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department contrast practices for abdominal/pelvic computed tomography-a national survey and comparison with the american college of radiology appropriateness criteria(®).
    Broder JS; Hamedani AG; Liu SW; Emerman CL
    J Emerg Med; 2013 Feb; 44(2):423-33. PubMed ID: 23164558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current utilization and procedural practices in pediatric whole-body MRI.
    Schooler GR; Davis JT; Daldrup-Link HE; Frush DP
    Pediatr Radiol; 2018 Aug; 48(8):1101-1107. PubMed ID: 29721598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium Deposition and Chronic Toxicity.
    Ramalho J; Ramalho M
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):765-778. PubMed ID: 28964466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function.
    Roberts DR; Lindhorst SM; Welsh CT; Maravilla KR; Herring MN; Braun KA; Thiers BH; Davis WC
    Invest Radiol; 2016 May; 51(5):280-9. PubMed ID: 26953564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study.
    Jakobsen JÅ; Quattrocchi CC; Müller FHH; Outteryck O; Alcázar A; Reith W; Fraga P; Panebianco V; Sampedro A; Pietura R
    BMC Med Imaging; 2021 Apr; 21(1):74. PubMed ID: 33879075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Imaging Safety Considerations of Gadolinium-Based Contrast Agents: Gadolinium Retention and Nephrogenic Systemic Fibrosis.
    McDonald JS; McDonald RJ
    Magn Reson Imaging Clin N Am; 2020 Nov; 28(4):497-507. PubMed ID: 33040991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists.
    Costa AF; van der Pol CB; Maralani PJ; McInnes MDF; Shewchuk JR; Verma R; Hurrell C; Schieda N
    Can Assoc Radiol J; 2018 Nov; 69(4):373-382. PubMed ID: 30249408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literature.
    Lancelot E; Froehlich J; Heine O; Desché P
    Acta Radiol; 2016 Nov; 57(11):1334-1343. PubMed ID: 26071496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus.
    Runge VM
    Invest Radiol; 2016 May; 51(5):273-9. PubMed ID: 26945278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.
    Trout AT; Dillman JR; Ellis JH; Cohan RH; Strouse PJ
    Pediatr Radiol; 2011 Oct; 41(10):1272-83. PubMed ID: 21594547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.
    Layne KA; Dargan PI; Archer JRH; Wood DM
    Br J Clin Pharmacol; 2018 Nov; 84(11):2522-2534. PubMed ID: 30032482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients.
    Uhlig J; Lücke C; Vliegenthart R; Loewe C; Grothoff M; Schuster A; Lurz P; Jacquier A; Francone M; Zapf A; Schülke C; ; May MS; Bremerich J; Lotz J; Gutberlet M;
    Eur Radiol; 2019 Jul; 29(7):3686-3695. PubMed ID: 31041566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.